Russia’s cancer vaccine ready for approval after successful testing: Report

The vaccine will first be used against colorectal cancer.

Published on: Sep 8, 2025, 02:55:29 IST

By HT News Desk

Prefer HTon Google

Share via

Copy link

Russia’s experimental cancer vaccine has passed preclinical testing, showing both safety and high effectiveness, the country's news agency TASS has reported, citing the head of the Federal Medical and Biological Agency (FMBA).

Cancer vaccines are currently available for some prostate and bladder cancers (Unsplash)

Veronika Skvortsova, the head of the Federal Medical and Biological Agency (FMBA), said at the Eastern Economic Forum (EEF) that research on the vaccine has been underway for several years, with the past three years devoted to mandatory preclinical studies.

“The vaccine is now ready for use; we are awaiting official approval,” she said, according to the Russian news agency.

The FMBA chief stressed that the preclinical results confirmed the drug’s safety, even after repeated doses, and demonstrated marked efficacy. Tumor shrinkage and slower progression were observed in 60–80% of cases, depending on the disease, while survival rates also improved.

According to Skvortsova, the vaccine will first be used against colorectal cancer. Work is also advancing on vaccines for glioblastoma and certain forms of melanoma, including ocular melanoma, which are in late stages of development, she added.

Skvortsova was speaking at the 10th Eastern Economic Forum, which was held in Vladivostok from September 3 to September 6.

The business program featured over 100 thematic sessions, divided into seven tracks. The forum brought together over 8,400 participants from more than 75 countries and territories.

Cancer vaccines are currently available for some prostate and bladder cancers, and more are being researched, as per the American Cancer Society.

ABOUT THE AUTHOR
HT News Desk
Follow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

Get the latest headlines from US news and global updates from Pakistan, Nepal, UK, Bangladesh, Russia and US Iran war Live, get all the latest headlines in one place on Hindustan Times.